SCHEMBL5771436

SCHEMBL5771436

CC1COC(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)OC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 3/20 0.67
CSNK1A1 P48729 2/20 0.67
RPS6KA3 P51812 1/20 0.67
MAPK14 Q16539 14/20 0.60
MAPK13 O15264 13/20 0.60
MAPK12 P53778 13/20 0.60
MAPK11 Q15759 13/20 0.60
MAPK9 P45984 4/20 0.60
RAF1 P04049 3/20 0.60
GCGR P47871 5/20 0.53
PRKD3 O94806 1/20 0.53
MAP4K4 O95819 1/20 0.53
FRK P42685 1/20 0.53
GSK3B P49841 1/20 0.53
PTK6 Q13882 1/20 0.53
PRKD2 Q9BZL6 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
BRAF P15056 1/20 0.52
CSNK1E P49674 1/20 0.49
ALOX5 P09917 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6911991 0.87 CSNK1A1 (0.57) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL6075437 0.86 CSNK1A1 (0.59) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL27518737 0.86 CSNK1A1 (0.61) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL5769549 0.85 MAPK13 (0.66) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL5770995 0.85 SOAT1 (0.68) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL6911987 0.85 MAPK13 (0.54) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL5770420 0.84 MAPK14 (0.58) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL5769743 0.83 CSNK1A1 (0.64) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL5769354 0.83 MAPK13 (0.60) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13
SCHEMBL5772456 0.83 MAPK13 (0.65) CSNK1DCSNK1A1RPS6KA3MAPK14MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100443481-C Imidazolyl-cyclic acetals RHONE POULENC RORER LTD (GB) 2008-12-17 CN claimed
US-20040038991-A1 Imidazolyl-cyclic acetals AVENTIS PHARMA LIMITED (GB) 2004-02-26 US claimed
CN-1273584-A Imidazolyl-cyclic acetals RHONE POULENC RORER LTD (GB) 2000-11-15 CN claimed
CN-100443481-C Imidazolyl-cyclic acetals RHONE POULENC RORER LTD (GB) 2008-12-17 CN disclosed
EP-0988301-B1 IMIDAZOLYL-CYCLIC ACETALS AVENTIS PHARMA LTD (GB) 2006-08-09 EP disclosed
US-6989395-B2 Imidazolyl-cyclic acetals AVENTIS PHARMA LIMITED (GB) 2006-01-24 US disclosed
US-20040038991-A1 Imidazolyl-cyclic acetals AVENTIS PHARMA LIMITED (GB) 2004-02-26 US disclosed
US-6602877-B1 Imidazolyl-cyclic acetals AVENTIS PHARMA LIMITED (GB) 2003-08-05 US disclosed
CN-1273584-A Imidazolyl-cyclic acetals RHONE POULENC RORER LTD (GB) 2000-11-15 CN disclosed
EP-0988301-A1 IMIDAZOLYL-CYCLIC ACETALS RHONE-POULENC RORER LIMITED (GB) 2000-03-29 EP disclosed
WO-1998056788-A1 IMIDAZOLYL-CYCLIC ACETALS RHONE-POULENC RORER LIMITED (GB) 1998-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038991-A1 Imidazolyl-cyclic acetals CBR1, LBR, CBR3 CSNK1D 621/4885CSNK1A1 1880/4885RPS6KA3 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.